HomeAI Drug Discovery

AI Drug Discovery

AI Drug Discovery

How AI Is Reshaping Biomarker Discovery in Drug Development

Polly Astill, Marketing Campaign Manager, Sygnature Discovery -
Biomarker discovery lies at the heart of the translational gap in drug development. Too often, programs stall, and compounds fail in late-stage trials. Retrospective...
AI Drug Discovery

How AI Is Changing Drug Discovery and What Still Stands in the Way

Daniel-Paul Bednarík, PhD, Chief Technology Officer, Black Canyon Bio, Inc. -
Developing a new medicine is difficult. Scientists must understand a disease, identify a biological target, find a compound or biologic that modulates it, and...
AI Drug Discovery

AI in Drug Discovery: It’s more than just complicated…it is complex

Michael N. Liebman, PhD, Managing Director, IPQ Analytics LLC -
Approximately $10B is being invested globally in the development and application of AI in Drug Discovery in 2026.  As a systems modeler, I see...

Hot Topics

Load more